e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Acute lung injury and ventilator-induced lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Keratinocyte growth factor2 pretreatment significantly reduces stress failure on high altitude pulmonary edema
J. She, Y. Song, C. Bai (Shanghai, China; San Francisco, United States Of America)
Source:
Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury
Session:
Acute lung injury and ventilator-induced lung injury
Session type:
Oral Presentation
Number:
1674
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. She, Y. Song, C. Bai (Shanghai, China; San Francisco, United States Of America). Keratinocyte growth factor2 pretreatment significantly reduces stress failure on high altitude pulmonary edema. Eur Respir J 2010; 36: Suppl. 54, 1674
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005
Hypoxia inducible factor-1? in human emphysema lung tissue
Source: Eur Respir J 2011; 37: 775-783
Year: 2011
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002
Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts
Source: Eur Respir J 2008; 31: 21-28
Year: 2008
The efficacy of prophylactic use of keratinocyte growth factor 2 with salmeterol in high altitude pulmonary oedema
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006
Pulmonary vascular hyperresponses during acute induction to high altitude hypoxia are associated with more pronounced changes of forced vital capacity in healthy subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 100s
Year: 2002
Decrease of physical capacity during acute induction at high altitude is associated with more pronounced increased pulmonary arterial pressure
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012
Role of hypoxia inducible factor 1alpha (HIF-1alpha) in delayed myocardial preconditioning induced by intermittent hypoxia (IH) in the rat
Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"
Year: 2006
Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia
Source: Eur Respir J 2001; 17: 681-687
Year: 2001
Protective effects of keratinocyte growth factor-2 on lipopolysacchride-induced acute lung injury
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats
Source: Eur Respir J 2010; 35: 584-591
Year: 2010
Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Lower level of keratinocyte growth factor contributes to severe lung injury in immunosuppressed rats model of pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 406s
Year: 2005
Increased recipient VEGF serum level is a risk factor for severe reperfusion edema after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 706s
Year: 2005
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003
VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis
Source: Eur Respir J 2006; 27: 957-963
Year: 2006
Electroporation mediated gene transfer of hepatocyte growth factor reduces bleomycin induced pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept